ANA Therapeutics starts oral niclosamide trial for Covid-19 treatment

This article was originally published here

The multicentre trial has been designed to assess the safety and efficacy of oral niclosamide formulation to treat patients with moderate Covid-19 disease. The study is said to

The post ANA Therapeutics starts oral niclosamide trial for Covid-19 treatment appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply